Novavax Inc. sell Citigroup Inc.
Start price
17.06.25
/
50%
€5.86
Target price
17.06.26
€5.19
Performance (%)
-4.94%
Price
17.12.25
€5.57
Summary
This prediction is currently active. With a performance of -4.94%, the SELL prediction for Novavax Inc. by Citigroup_Inc_ is down slightly. This prediction currently runs until 17.06.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | -3.351% | -3.351% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Citigroup_Inc_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $6.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat